NCT06489782View on ClinicalTrials.gov

Developing a Novel Human Laboratory Paradigm for AUD Medication Screening

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 15, 2026

Study Completion Date

June 30, 2026

Conditions
Alcohol Use Disorder
Interventions
OTHER

Model 1

Model 1 examines the impact of alcohol cues and alcohol availability on latency to start drinking and amount consumed of a 0.12 g/dL dose of alcohol during a 2-hour ad-libitum period.

OTHER

Model 2

Model 2 examines the impact of alcohol cues and alcohol availability and a priming dose of alcohol (.04 g/dL) on latency to start drinking and amount consumed of a 0.12 g/dL dose of alcohol during a 2-hour ad-libitum period.

Trial Locations (1)

06510

RECRUITING

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER